According to research report the global IVD Quality Control Market is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582
The
IVD quality control market is primarily driven by increasing demands
for laboratory accreditation, as well as the rising number of accredited
laboratories and growing adoption of third-party quality controls.
However, the lack of regulations for clinical laboratory accreditation
in several emerging countries will challenge market growth.
On
the basis of type, the quality control products market is segmented into
serum/plasma-based controls, whole blood-based controls, urine-based
controls, and other controls (controls manufactured from spinal fluid,
lipoprotein extracts, and immunoproteins). The serum/plasma-based
controls segment is expected to account for the largest market share in
2019. The large share of this segment is mainly attributed to the
greater uptake of serum/plasma-based quality controls among laboratories
and the widening application areas of these controls for various IVD
tests.
Based on applications, the IVD quality control market is
segmented into clinical chemistry, immunochemistry, hematology,
coagulation & hemostasis, microbiology, molecular diagnostics, and
other applications (ESR, urine chemistry, immunology, cardiac
assessment, and blood morphology). The molecular diagnostics segment is
expected to grow at the highest CAGR during the forecast period. This
growth can be attributed to the rising prevalence of infectious
diseases, cancer, and various genetic disorders; the growing demand for
blood screening; and the increasing application of molecular diagnostic
technologies in pharmacogenetics and point-of-care testing.
The
North America is expected to account for the largest share of the global
IVD quality control market in 2020, followed by Europe. The large share
of the North America can be attributed to the highly developed
healthcare system in the US and Canada, and the presence of a large
number of leading IVD quality control vendors & national clinical
laboratories & hospitals in this region.
Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198032582
The prominent players in this IVD Quality Control Market
are Bio-Rad Laboratories Inc. (US), Randox Laboratories Ltd. (UK),
Thermo Fisher Scientific Inc. (US), Technopath Clinical Diagnostics
(Ireland), Bio-Techne Corporation (US), Fortress Diagnostics (UK),
SeraCare Life Sciences Inc. (US), SERO AS (Norway), Roche Diagnostics
(Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US),
and Abbott Laboratories Inc. (US).
